HIGHLIGHTS
- who: Iris K. Minichmayr and colleagues from the Department of Pharmacy, Uppsala University, POBox, Uppsala, Sweden have published the Article: Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against Pseudomonas aeruginosa to Clinical Settings, in the Journal: Antibiotics 2022, 11, 1036. of /2022/
- what: This study aimed to investigate the impact of the shape of human pharmacokinetic (concentration-time) profiles of meropenem on the bacterial dynamics (growth/killing over time) of P. aeruginosa given diverse patient-, infection site-, and pathogen-related characteristics using a semi-mechanistic PKPD model versus . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.